Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00082914
First received: May 14, 2004
Last updated: June 18, 2013
Last verified: December 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given